Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 3/20 | 0.66 |
| ▸ | CTSS | P25774 | 3/20 | 0.66 |
| ▸ | CTSK | P43235 | 3/20 | 0.66 |
| ▸ | CTSH | P09668 | 1/20 | 0.66 |
| ▸ | APLNR | P35414 | 2/20 | 0.57 |
| ▸ | OPRM1 | P35372 | 7/20 | 0.52 |
| ▸ | OPRK1 | P41145 | 7/20 | 0.52 |
| ▸ | MC4R | P32245 | 2/20 | 0.50 |
| ▸ | MC5R | P33032 | 1/20 | 0.50 |
| ▸ | MC3R | P41968 | 1/20 | 0.50 |
| ▸ | MC1R | Q01726 | 1/20 | 0.50 |
| ▸ | F2 | P00734 | 2/20 | 0.49 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31437178 | 0.97 | CTSL (0.63) | CTSLCTSSCTSKCTSHAPLNR | |
| SCHEMBL31437190 | 0.96 | CTSL (0.62) | CTSLCTSSCTSKCTSHAPLNR | |
| SCHEMBL31437160 | 0.90 | CTSL (0.56) | CTSLCTSSCTSKCTSHAPLNR | |
| SCHEMBL30910841 | 0.89 | CTSL (0.52) | CTSLCTSSCTSKCTSHAPLNR | |
| SCHEMBL31467769 | 0.87 | CTSL (0.55) | CTSLCTSSCTSKCTSHAPLNR | |
| SCHEMBL7200319 | 0.84 | CTSL (0.49) | CTSLCTSSCTSKCTSHAPLNR | |
| SCHEMBL7200318 | 0.84 | CTSL (0.49) | CTSLCTSSCTSKCTSHAPLNR | |
| SCHEMBL31437191 | 0.83 | CTSL (0.50) | CTSLCTSSCTSKCTSHAPLNR | |
| SCHEMBL31437181 | 0.82 | MC4R (0.51) | CTSLCTSSCTSKCTSHAPLNR | |
| SCHEMBL29695502 | 0.82 | APLNR (0.64) | CTSLCTSSCTSKCTSHAPLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025037992-A1 | NEW PEPTIDES AND USE THEREOF | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | claimed |
| WO-2025037992-A1 | NEW PEPTIDES AND USE THEREOF | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |
| WO-2025037992-A1 | NEW PEPTIDES AND USE THEREOF | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |
| WO-2025037993-A1 | DOSAGE FORM FOR PEPTIDE AGENTS | MAJEWSKI FILIP (PL) | 2025-02-20 | — | — | WO | disclosed |